HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonas Nilsson Selected Research

Breast Neoplasms (Breast Cancer)

3/2021Socioeconomy as a prognostic factor for location of death in Swedish palliative cancer patients.
1/2018LC-MS/MS characterization of xyloside-primed glycosaminoglycans with cytotoxic properties reveals structural diversity and novel glycan modifications.
7/2006Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer.
6/2006Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401.
6/2005Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
10/2003Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonas Nilsson Research Topics

Disease

22Neoplasms (Cancer)
11/2023 - 03/2006
6Breast Neoplasms (Breast Cancer)
03/2021 - 10/2003
5Infections
04/2022 - 04/2013
5Alzheimer Disease (Alzheimer's Disease)
01/2019 - 01/2011
4Neoplasm Metastasis (Metastasis)
01/2019 - 08/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 10/2015
3Melanoma (Melanoma, Malignant)
01/2019 - 01/2015
3Macular Degeneration (Age-Related Maculopathy)
01/2017 - 08/2016
3Atrial Fibrillation
06/2013 - 08/2012
3Atrial Flutter (Flutter, Atrial)
06/2013 - 08/2012
2Amyloid Plaque
03/2023 - 05/2012
2Insulinoma
01/2021 - 01/2021
2Epilepsy (Aura)
01/2017 - 12/2016
2Uveal melanoma
08/2015 - 08/2014
2Muscular Dystrophies (Muscular Dystrophy)
11/2012 - 09/2010
2Glioma (Gliomas)
10/2006 - 03/2006
2Carcinoma (Carcinomatosis)
07/2006 - 01/2002
2Urinary Bladder Neoplasms (Bladder Cancer)
03/2004 - 01/2002
1Communicable Diseases (Infectious Diseases)
04/2024
1Gastroenteritis
04/2024
1Obesity
02/2024
1Weight Gain
02/2024
1Fascioliasis
11/2023
1Dupuytren Contracture (Dupuytrens Contracture)
10/2023
1Mucopolysaccharidoses
10/2023
1Amyloidosis
03/2023
1Respiratory Insufficiency (Respiratory Failure)
12/2022
1Nausea
11/2022
1Vomiting
11/2022
1Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
09/2022
1Colonic Neoplasms (Colon Cancer)
04/2022
1Sudden Infant Death (SID)
04/2022
1Rheumatoid Arthritis
01/2022
1Brain Neoplasms (Brain Tumor)
03/2021
1Malaria
12/2020
1Caliciviridae Infections
11/2020
1Herpes Zoster
02/2019
1Virus Diseases (Viral Diseases)
02/2019

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
11/2023 - 08/2004
6Biomarkers (Surrogate Marker)IBA
10/2023 - 07/2006
4Glycoproteins (Glycoprotein)IBA
04/2024 - 04/2013
4Amyloid (Amyloid Fibrils)IBA
01/2019 - 07/2011
3Polysaccharides (Glycans)IBA
04/2024 - 10/2013
3Blood Group Antigens (Blood Groups)IBA
04/2024 - 11/2020
3ChondroitinIBA
09/2022 - 01/2018
3Dermatan SulfateIBA
09/2022 - 01/2018
3GlycopeptidesIBA
01/2021 - 12/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 05/2015
3Ranibizumab (Lucentis)FDA Link
01/2017 - 08/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2013 - 01/2002
3DronedaroneFDA Link
06/2013 - 08/2012
3LigandsIBA
04/2013 - 09/2010
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2006 - 10/2003
3Epirubicin (Ellence)FDA LinkGeneric
06/2006 - 10/2003
2VaccinesIBA
11/2023 - 02/2019
2GlycosaminoglycansIBA
10/2023 - 09/2022
2Peptides (Polypeptides)IBA
01/2019 - 07/2011
2N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2018 - 10/2002
2Phosphotransferases (Kinase)IBA
08/2017 - 06/2011
2RNA (Ribonucleic Acid)IBA
07/2017 - 01/2015
2ScandiumIBA
08/2015 - 08/2014
2GC 1 compoundIBA
02/2015 - 04/2013
2Anti-Arrhythmia AgentsIBA
06/2013 - 01/2013
2Dystroglycans (Dystroglycan)IBA
11/2012 - 09/2010
2CaspasesIBA
11/2011 - 06/2011
2Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
06/2006 - 10/2003
2Fluorouracil (Carac)FDA LinkGeneric
06/2006 - 10/2003
2Carboplatin (JM8)FDA LinkGeneric
06/2006 - 10/2003
2Methotrexate (Mexate)FDA LinkGeneric
03/2004 - 01/2002
1CollagenIBA
02/2024
1Fibrillar CollagensIBA
02/2024
1LipidsIBA
02/2024
1Collagenases (Collagenase)FDA Link
10/2023
1ORALIT (ORS)IBA
02/2023
1Propofol (Diprivan)FDA LinkGeneric
12/2022
1IsofluraneFDA LinkGeneric
12/2022
1Palonosetron (Aloxi)FDA Link
11/2022
1AntiemeticsIBA
11/2022
1netupitantIBA
11/2022
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
09/2022
1Abatacept (Orencia)FDA Link
01/2022
1Chromogranin AIBA
01/2021
1LyasesIBA
01/2021
1PronaseIBA
01/2021
1AnionsIBA
01/2021
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
12/2020
1Chondroitin Sulfate ProteoglycansIBA
12/2020
1Proteoglycans (Proteoglycan)IBA
12/2020
1CarbohydratesIBA
11/2020
1GlycosphingolipidsIBA
11/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Subunit VaccinesIBA
02/2019
1Melphalan (Alkeran)FDA LinkGeneric
01/2019

Therapy/Procedure

9Therapeutics
10/2023 - 10/2003
5Drug Therapy (Chemotherapy)
11/2022 - 01/2002
3Palliative Care (Palliative Therapy)
11/2023 - 05/2015
2Terminal Care (Care, Terminal)
11/2023 - 12/2017
2Combination Drug Therapy (Combination Chemotherapy)
03/2004 - 01/2002
1Lasers (Laser)
03/2023
1Immunotherapy
10/2021